Displaying drugs 1476 - 1500 of 2773 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Lomifylline | 278.312 C13H18N4O3 |  | Not Annotated | Alkaloids / Drugs for Obstructive Airway Diseases / Heterocyclic Compounds, Fused-Ring / Purines / Purinones / Xanthine derivatives |
| Lomitapide | 693.7204 C39H37F6N3O2 |  | A microsomal triglyceride transfer protein inhibitor used to lower cholesterol associated with homozygous familial hypercholesterolemia (HoFH), reducing risk of cardiovascular events such as myocardial infarction and stroke. | Hypolipidemic Agents Indicated for Hyperlipidemia / Microsomal Triglyceride Transfer Protein Inhibitor |
| Lomustine | 233.695 C9H16ClN3O2 |  | An alkylating agent used as a part of chemotherapeutic regimens for the treatment of primary and metastatic brain tumors as well as refractory or relapsed Hodgkin's disease in addition to surgical and/or radiotherapeutic treatments. | Nitrosoureas |
| Lonafarnib | 638.822 C27H31Br2ClN4O2 |  | A potent farnesyl transferase inhibitor used to reduce mortality associated with Hutchinson-Gilford progeria syndrome (HGPS) and other progeroid laminopathies. | Various Alimentary Tract and Metabolism Products |
| Loperamide | 477.038 C29H33ClN2O2 |  | A long acting antidiarrheal used to control nonspecific diarrhea and chronic diarrhea caused by inflammatory bowel disease, or gastroenteritis. | Antipropulsives |
| Lopinavir | 628.8008 C37H48N4O5 |  | An HIV-1 protease inhibitor used in combination with ritonavir to treat human immunodeficiency virus (HIV) infection. | Cytochrome P-450 CYP3A Inhibitors / HIV Protease Inhibitors / Protease Inhibitors / Pyrimidinones |
| Loracarbef | 349.769 C16H16ClN3O4 |  | Used to treat upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus,... | Anti-Bacterial Agents / Second-Generation Cephalosporins |
| Loratadine | 382.883 C22H23ClN2O2 |  | A second generation antihistamine used to manage the symptoms of allergic rhinitis. | Anti-Allergic Agents / Antipruritics / Histamine H1 Antagonists, Non-Sedating |
| Lorazepam | 321.158 C15H10Cl2N2O2 |  | A short-acting benzodiazepine commonly used to treat panic disorders, severe anxiety, and seizures. | Anti-Anxiety Agents |
| Lorcaserin | 195.69 C11H14ClN |  | A serotonin 2C receptor agonist used in conjunction with physical activity and calorie restriction for weight loss in obese patients with a body mass index (BMI) of 30 and above, and in overweight patients with weight-related comorbidities. | Centrally Acting Antiobesity Products |
| Lorlatinib | 406.421 C21H19FN6O2 |  | An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors |
| Lormetazepam | 335.185 C16H12Cl2N2O2 |  | A benzodiazepine indicated in the treatment of anxiety and the induction of anesthesia. | Benzodiazepines and benzodiazepine derivatives |
| Lornoxicam | 371.81 C13H10ClN3O4S2 |  | An NSAID indicated in the treatment of mild to moderate pain, as well as rheumatoid arthritis and osteoarthritis. | Oxicams |
| Lorpiprazole | 405.469 C21H26F3N5 |  | In 2016, lorpiprazole was classified in the "Chemical structure-related drug-like criteria of global approved drugs" as an antipsychotic and anxiolytic. An antipsychotic is a medication used to treat a state... | Antidepressive Agents / Central Nervous System Depressants / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Serotonin 5-HT2 Receptor Antagonists / Serotonin 5-HT2A Receptor Antagonists / Serotonin 5-HT2C Receptor Antagonists / Serotonin Agents / Serotonin Modulators / Serotonin Receptor Antagonists |
| Losartan | 422.911 C22H23ClN6O |  | An angiotensin receptor blocker used to treat hypertension and diabetic nephropathy, and is used to reduce the risk of stroke. | Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics |
| Loteprednol | 394.889 C21H27ClO5 |  | A corticosteroid indicated in the treatment of pain and inflammation after cataract surgery. | Androstadienes / Anti-Allergic Agents / Corticosteroids |
| Loteprednol etabonate | 466.96 C24H31ClO7 |  | A corticosteroid used to treat allergic conjunctivitis as well as inflammation and pain after ocular surgery. | Androstadienes / Anti-Allergic Agents / Corticosteroids |
| Lotilaner | 596.75 C20H14Cl3F6N3O3S |  | An antiparasitic agent used to treat Demodex blepharitis. | Antiparasitic Agents / Ectoparasiticide / Ectoparasiticides, Incl. Scabicides / Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents / Sulfur Compounds |
| Lovastatin | 404.5396 C24H36O5 |  | An HMG-CoA reductase inhibitor used to lower LDL cholesterol and reduce the risk of cardiovascular disease and associated conditions, including myocardial infarction and stroke. | Anticholesteremic Agents / Drugs causing inadvertant photosensitivity / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypolipidemic Agents Indicated for Hyperlipidemia |
| Loxapine | 327.808 C18H18ClN3O |  | A antipsychotic used for the treatment of schizophrenia. | Diazepines, Oxazepines, Thiazepines and Oxepines |
| Loxoprofen | 246.3016 C15H18O3 |  | An NSAID used to treat pain and inflammation in musculoskeletal conditions. | Antiinflammatory Preparations, Non-Steroids for Topical Use |
| Lubiprostone | 390.468 C20H32F2O5 |  | A prostaglandin derivative used to treat constipation caused by irritable bowel syndrome and opioid-use. | Chloride Channel Agonists |
| Luliconazole | 354.27 C14H9Cl2N3S2 |  | A topical antifungal agent used to treat fungal infections. | Imidazole and Triazole Derivatives |
| Lumacaftor | 452.414 C24H18F2N2O5 |  | A protein chaperone used in combination with ivacaftor for the treatment of cystic fibrosis in patients who are homozygous for the F508del mutation in the CFTR gene. | Amines / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inducers (strong) / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strong) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Dioxoles / Heterocyclic Compounds, Fused-Ring / P-glycoprotein inducers / P-glycoprotein inhibitors / Pyridines |
| Lumateperone | 393.506 C24H28FN3O |  | A novel 2nd generation antipsychotic used to manage both positive and negative symptoms in patients with schizophrenia. | Butyrophenone Derivatives |
Displaying drugs 1476 - 1500 of 2773 in total